Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

In this Discussion

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Credit Suisse Investors / Harris Associates Target Board Over Archegos ...

edited April 28 in Fund Discussions
“Top shareholders said they would vote against re-electing key Credit Suisse Group AG board members, a broadside against the bank’s leadership following a $5.5 billion loss from hedge fund Archegos Capital Management.

“At the bank’s annual meeting this Friday, Harris Associates* and Norges Bank Investment Management said they would vote against the reappointment of Andreas Gottschling, chairman of the bank’s risk committee. Mr. Gottschling joined the board in 2017 from the top risk job at Austria’s Erste Group Bank AG.

“David Herro, a partner at Harris Associates with a roughly 8% stake in Credit Suisse, said he would vote against Mr. Gottschling because he was the director in charge of risk.

“Norges, an arm of Norway’s central bank that runs its sovereign oil fund, owns around 3% of Credit Suisse. It said it would also oppose re-electing the lead independent director Severin Schwan, who is chief executive at Roche Holding AG , and Richard Meddings, a veteran British banker who joined the board last year ... Under Swiss rules, more than half of voting shares must go against a Director to block re-election.”

From: The Wall Street Journal - April 27, 2021 - Reported by Margot Patrick

* Since Harris Associates operates the Oakmark Funds, I’ve elected to include this under fund discussions.


  • It is about time the major investors are holding Credit Suisse board members accountable. These people do not deserve to serve another term.
Sign In or Register to comment.